The Abdala vaccine effectiveness study is ongoing. This study involves collecting data from all the municipalities of Cuba, which covers a universe of more than 300,000 people. That is, the clinical study is scaled from 30,000 – 40,000 to 300,000 or more subjects. This, in addition, has a scientific methodology, it is necessary to fill in the databases in all the vaccinated municipalities; of those vaccinated, know how many doses they received; of those not vaccinated, why they were not vaccinated, and then calculate and control the statistics to obtain the effectiveness data. It also goes through registering all the people who had a positive SARS-CoV-2, and how they evolved. At the moment, the data is being collected, in order to make it known as one more scientific study.
